OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential role of the orexin reward system in future treatments for opioid drug abuse
Shahram Zarrabian, Esmail Riahi, Sara Karimi, et al.
Brain Research (2018) Vol. 1731, pp. 146028-146028
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71

Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder
Robert Suchting, Jin H. Yoon, Guadalupe G. San Miguel, et al.
Brain Research (2019) Vol. 1731, pp. 146359-146359
Closed Access | Times Cited: 45

Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.
Andrew S. Huhn, Patrick H. Finan
Experimental and Clinical Psychopharmacology (2021) Vol. 30, Iss. 6, pp. 1024-1035
Open Access | Times Cited: 38

Translational models of stress and resilience: An applied neuroscience methodology review
Zeynep Seda Albayrak, Andreia Vaz, Joeri Bordes, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104064-104064
Open Access | Times Cited: 4

Analysis of Anxiety Disorders and Post-Traumatic Stress Disorders for Screening Anxiolytic Drugs and Linking Preclinical and Clinical Research
Anna Kozłowska, Wan-Jiun Ma, Bai‐Chuang Shyu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1414-1414
Open Access

Effect of suvorexant on morphine tolerance and dependence in mice: Role of NMDA, AMPA, ERK and CREB proteins
Peyman Esmaili‐Shahzade‐Ali‐Akbari, Hossein Hosseinzadeh, Soghra Mehri
NeuroToxicology (2021) Vol. 84, pp. 64-72
Closed Access | Times Cited: 31

The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11

Unveiling Morphine: A Rapid and Selective Fluorescence Sensor for Forensic and Medical Analysis
Ramin Boroujerdi, Andrew A. Butt, Richard Paul, et al.
Sensors (2024) Vol. 24, Iss. 6, pp. 1722-1722
Open Access | Times Cited: 4

Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Alessandra Matzeu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9

First‐in‐human study with ACT‐539313, a novel selective orexin‐1 receptor antagonist
Priska Kaufmann, Marion Anliker‐Ort, Georg Golor, et al.
British Journal of Clinical Pharmacology (2020) Vol. 86, Iss. 7, pp. 1377-1386
Open Access | Times Cited: 23

Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 21

Distinct roles for orexin-1 and orexin-2 receptors in the dentate gyrus of the hippocampus in the methamphetamine-seeking behavior in the rats
Farzaneh Nazari-Serenjeh, Ronak Azizbeigi, Mina Rashvand, et al.
Life Sciences (2022) Vol. 312, pp. 121262-121262
Closed Access | Times Cited: 13

Objective and subjective measurement of sleep in people who use substances: Emerging evidence and recommendations from a systematic review
Heather E. Webber, Jessica C. Badawi, Joy M. Schmitz, et al.
Journal of Sleep Research (2024)
Closed Access | Times Cited: 2

Similar role of mPFC orexin-1 receptors in the acquisition and expression of morphine- and food-induced conditioned place preference in male rats
Shole Jamali, Shahram Zarrabian, Abbas Haghparast
Neuropharmacology (2021) Vol. 198, pp. 108764-108764
Closed Access | Times Cited: 16

The Role of Orexin-1 Receptors Within the Hippocampal CA1 Area in the Extinction and Reinstatement of Methamphetamine-Seeking Behaviors
Ali Veisi, Hossein Khaleghzadeh‐Ahangar, Mojdeh Fattahi, et al.
Neurochemical Research (2022) Vol. 48, Iss. 2, pp. 671-680
Closed Access | Times Cited: 12

Involvement of orexin receptors within the hippocampal dentate gyrus in morphine-induced reinstatement in food-deprived rats
Mahsa Pourhamzeh, Roghayeh Mozafari, Shole Jamali, et al.
Behavioural Brain Research (2019) Vol. 375, pp. 112155-112155
Closed Access | Times Cited: 16

Involvement of orexin-2 receptors in the CA1 region of the hippocampus in the extinction and reinstatement of methamphetamine-induced conditioned place preference in the rats
Haleh Amirteymori, Ali Veisi, Hossein Khaleghzadeh‐Ahangar, et al.
Peptides (2022) Vol. 160, pp. 170926-170926
Closed Access | Times Cited: 9

Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation
Amy C. Beckenstrom, Preciosa Coloma, Gerard R. Dawson, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 147, pp. 105107-105107
Open Access | Times Cited: 5

The blockade of orexin receptors within the dentate gyrus of the hippocampus attenuated methamphetamine-induced reward learning during conditioning place preference
Shaghayegh Modaberi, Haleh Amirteymori, Somaye Mesgar, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 226, pp. 173559-173559
Closed Access | Times Cited: 5

Deep Brain Stimulation of the Lateral Hypothalamus Facilitates Extinction and Prevents Reinstatement of Morphine Place Preference in Rats
Moein Minbashi Moeini, Seyed Shahabeddin Sadr, Esmail Riahi
Neuromodulation Technology at the Neural Interface (2021) Vol. 24, Iss. 2, pp. 240-247
Closed Access | Times Cited: 12

Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date
Reda Chalhoub, Peter W. Kalivas
Drugs (2020) Vol. 80, Iss. 15, pp. 1509-1524
Open Access | Times Cited: 12

The Paradoxical Effect Hypothesis of Abused Drugs in a Rat Model of Chronic Morphine Administration
Yinghao Yu, Alan Bo-Han He, Michelle Liou, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 15, pp. 3197-3197
Open Access | Times Cited: 11

Pleasure, addiction, and hypocretin (orexin)
R. L. McGregor, Thomas C. Thannickal, Jerome M. Siegel
Handbook of clinical neurology (2021), pp. 359-374
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top